What is the Krsnaa Diagnostics Ltd share price today?

The share price of NSE:KRSNAA-EQ on 01 Oct 2026 (as of 15:04:05 IST) is ₹555.

What is the NSE:KRSNAA-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:KRSNAA-EQ 52 week high low range shows a high of ₹848.1 and a low of ₹515.

What is the Krsnaa Diagnostics Ltd market cap?

As on 01 Oct 2026, Krsnaa Diagnostics Ltd market cap is ₹18157500000.

What is the shareholding pattern of Krsnaa Diagnostics Ltd Stock?

The shareholding pattern of Krsnaa Diagnostics Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 27.11% Foreign Institutional Investors (FII): 4.28% Domestic Institutional Investors (DII): 4.34% Mutual Funds: 10.17% Retail & Others: 54.1% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Krsnaa Diagnostics Ltd?

The Price-to-Earnings (PE) ratio of Krsnaa Diagnostics Ltd is 18.6308, and the Price-to-Book (PB) ratio is 1.7388, as on 01 Oct 2026.

Krsnaa Diagnostics Share Price

485.10-0.70 (-0.14%)

-38.60% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.14%

1 Week

-3.70%

1 Month

-13.27%

3 Month

-13.36%

6 Month

-19.08%

YTD

-32.75%

1 Year

-38.60%

5 Year

-27.81%

10 Year

Max

-51.76%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

480.75

463.10

High

492.45

536.65

564.00

598.00

622.55

838.00

About

Krsnaa Diagnostics Limited is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical Read more

Hospital & Healthcare Services

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

APOLLOHOSPNSE

MAXHEALTHNSE

MANIPALHOSNSE

ASTERDMNSE

FORTISNSE

NHNSE

MEDANTANSE

LALPATHLABNSE

KIMSNSE

AGARWALEYENSE

KRSNAANSE

LTP

1W Low

1W High

Market cap (₹)

8515+67 (0.79%)

8301

8575

1,21,412Cr

919.65+59.65 (6.94%)

863.80

926.70

87,015Cr

667.75-1.4 (-0.21%)

633.25

670.45

84,796Cr

691.35+10.2 (1.50%)

672

693.45

59,431Cr

788.4+20.25 (2.64%)

754.65

795.50

59,227Cr

1902+181.8 (10.57%)

1732.50

1926

38,205Cr

1389.4+119.1 (9.38%)

1270.30

1423.60

35,671Cr

1931.2+24.8 (1.30%)

1856.50

1939.40

32,373Cr

735.8+34 (4.84%)

702.40

746.80

30,682Cr

522.35+13.15 (2.58%)

502

525.50

16,250Cr

487.55-16.2 (-3.22%)

463.10

536.65

1,575Cr

Krsnaa Diagnostics Share Price

485.10-0.70 (-0.14%)

-38.60% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years17%

Last year8%

Compounded Profit Growth

10 years-

5 years-

3 years18%

Last year31%

Stock Price CAGR

10 years-

5 years-6%

3 years-12%

1 year-39%

Return on Equity

10 years9%

5 years9%

3 years9%

Last year11%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	17%	8%
-	-	18%	31%
-	-6%	-12%	-39%
9%	9%	9%	11%

Peer Comparison

Symbol

APOLLOHOSP

MAXHEALTH

MANIPALHOS

ASTERDM

FORTIS

MEDANTA

LALPATHLAB

KIMS

AGARWALEYE

KRSNAA

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
8,525	₹121412 Cr	58.11	40.39	207.67	₹1942 Cr
916	₹87015 Cr	63.03	4.26	19.36	₹1442 Cr
656.5	₹84796 Cr	95.03	1.96	11.95	₹892 Cr
689.95	₹59431 Cr	186.49	0.31	6.76	₹388 Cr
789.2	₹59227 Cr	56.52	3.53	20.1	₹1042 Cr
1,912	₹38205 Cr	44.49	14.73	71.14	₹806 Cr
1,411.4	₹35671 Cr	57.68	8.21	32.95	₹556 Cr
1,904.1	₹32373 Cr	59.74	10.11	42.51	₹505 Cr
737.05	₹30682 Cr	150.18	1.04	12.74	₹241 Cr
520.2	₹16250 Cr	109.52	1.43	13.88	₹133 Cr
485.1	₹1575 Cr	16.06	7.58	61.77	₹101 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
₹271 Cr	₹236 Cr	₹193 Cr	₹181 Cr	₹206 Cr	₹193 Cr	₹186 Cr	₹175 Cr	₹186 Cr	₹170 Cr	₹166 Cr	₹158 Cr	₹155 Cr	₹140 Cr	₹133 Cr	₹118 Cr	₹123 Cr	₹113 Cr	₹108 Cr	₹106 Cr	₹108 Cr	₹132 Cr
₹6 Cr	₹7 Cr	₹31 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹9 Cr	₹5 Cr	₹7 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr
₹277 Cr	₹243 Cr	₹224 Cr	₹185 Cr	₹210 Cr	₹197 Cr	₹190 Cr	₹184 Cr	₹191 Cr	₹178 Cr	₹171 Cr	₹162 Cr	₹160 Cr	₹144 Cr	₹139 Cr	₹123 Cr	₹127 Cr	₹117 Cr	₹112 Cr	₹111 Cr	₹111 Cr	₹136 Cr
₹229 Cr	₹206 Cr	₹160 Cr	₹157 Cr	₹170 Cr	₹163 Cr	₹155 Cr	₹152 Cr	₹159 Cr	₹149 Cr	₹141 Cr	₹142 Cr	₹143 Cr	₹124 Cr	₹113 Cr	₹103 Cr	₹105 Cr	₹97 Cr	₹91 Cr	₹87 Cr	₹87 Cr	₹101 Cr
₹77 Cr	₹65 Cr	₹86 Cr	₹50 Cr	₹63 Cr	₹55 Cr	₹57 Cr	₹54 Cr	₹54 Cr	₹50 Cr	₹48 Cr	₹41 Cr	₹36 Cr	₹36 Cr	₹40 Cr	₹34 Cr	₹35 Cr	₹32 Cr	₹32 Cr	₹34 Cr	₹35 Cr	₹45 Cr
₹15 Cr	₹15 Cr	₹12 Cr	₹8 Cr	₹8 Cr	₹6 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹7 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹8 Cr	₹6 Cr
₹33 Cr	₹22 Cr	₹52 Cr	₹20 Cr	₹32 Cr	₹27 Cr	₹29 Cr	₹25 Cr	₹25 Cr	₹23 Cr	₹23 Cr	₹16 Cr	₹13 Cr	₹18 Cr	₹24 Cr	₹18 Cr	₹20 Cr	₹19 Cr	₹20 Cr	₹21 Cr	₹17 Cr	₹29 Cr
₹25 Cr	₹17 Cr	₹42 Cr	₹15 Cr	₹24 Cr	₹21 Cr	₹21 Cr	₹19 Cr	₹20 Cr	₹18 Cr	₹19 Cr	₹13 Cr	₹10 Cr	₹15 Cr	₹19 Cr	₹14 Cr	₹15 Cr	₹14 Cr	₹18 Cr	₹16 Cr	₹13 Cr	₹22 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
—	—	—	—	—
₹16 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹16 Cr
₹8 Cr	₹6 Cr	₹2 Cr	₹3 Cr	₹2 Cr
₹956 Cr	₹860 Cr	₹791 Cr	₹720 Cr	₹667 Cr
₹956 Cr	₹860 Cr	₹791 Cr	₹720 Cr	₹667 Cr
₹980 Cr	₹883 Cr	₹810 Cr	₹739 Cr	₹684 Cr
₹437 Cr	₹19 Cr	₹6 Cr	₹11 Cr	₹20 Cr
₹25 Cr	₹19 Cr	₹15 Cr	₹11 Cr	₹7 Cr
₹98 Cr	₹49 Cr	₹57 Cr	₹47 Cr	₹43 Cr
₹3 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹32 L
₹563 Cr	₹90 Cr	₹79 Cr	₹71 Cr	₹70 Cr
—	—	—	—	—
₹63 Cr	₹97 Cr	₹82 Cr	₹62 Cr	₹77 Cr
₹189 Cr	₹60 Cr	₹99 Cr	₹35 Cr	₹42 Cr
₹11 Cr	₹139 Cr	₹96 Cr	₹0	₹0
₹12 Cr	₹9 Cr	₹4 Cr	₹2 Cr	₹2 Cr
₹275 Cr	₹305 Cr	₹281 Cr	₹99 Cr	₹121 Cr
₹1819 Cr	₹1278 Cr	₹1170 Cr	₹909 Cr	₹875 Cr
₹66 Cr	₹55 Cr	₹23 Cr	₹4 Cr	₹4 Cr
₹491 Cr	₹166 Cr	₹107 Cr	₹17 Cr	₹26 Cr
—	—	—	—	—
₹1042 Cr	₹971 Cr	₹874 Cr	₹627 Cr	₹491 Cr
₹386 Cr	₹300 Cr	₹226 Cr	₹156 Cr	₹106 Cr
₹656 Cr	₹670 Cr	₹647 Cr	₹471 Cr	₹386 Cr
₹208 Cr	₹3 Cr	₹10 Cr	₹25 Cr	₹28 Cr
₹57 Cr	₹32 Cr	₹29 L	₹29 L	₹29 L
₹57 Cr	₹32 Cr	₹29 L	₹29 L	₹29 L
₹124 Cr	₹45 Cr	₹62 Cr	₹26 Cr	₹18 Cr
₹35 Cr	₹114 Cr	₹29 Cr	₹163 Cr	₹109 Cr
₹1080 Cr	₹864 Cr	₹749 Cr	₹686 Cr	₹541 Cr
—	—	—	—	—
₹27 Cr	₹29 Cr	₹36 Cr	₹25 Cr	₹9 Cr
₹296 Cr	₹278 Cr	₹176 Cr	₹73 Cr	₹58 Cr
₹361 Cr	₹68 Cr	₹175 Cr	₹109 Cr	₹242 Cr
₹24 Cr	₹30 Cr	₹24 Cr	₹10 Cr	₹8 Cr
₹31 Cr	₹9 Cr	₹10 Cr	₹6 Cr	₹17 Cr
₹738 Cr	₹414 Cr	₹421 Cr	₹223 Cr	₹334 Cr
₹463 Cr	₹109 Cr	₹140 Cr	₹124 Cr	₹213 Cr
₹1819 Cr	₹1278 Cr	₹1170 Cr	₹909 Cr	₹875 Cr
₹300	₹271	₹250	₹234	₹217
₹300	₹271	₹250	₹234	₹217

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
₹130 Cr	₹103 Cr	₹70 Cr	₹80 Cr	₹87 Cr
₹87 Cr	₹98 Cr	₹70 Cr	₹45 Cr	₹49 Cr
-₹47 Cr	-₹93 Cr	-₹97 Cr	-₹36 Cr	-₹66 L
₹171 Cr	₹107 Cr	₹43 Cr	₹89 Cr	₹135 Cr
₹143 Cr	₹87 Cr	₹24 Cr	₹76 Cr	₹128 Cr
-₹396 Cr	-₹100 Cr	-₹129 Cr	-₹109 Cr	-₹241 Cr
₹279 Cr	₹14 Cr	₹84 Cr	-₹33 Cr	₹176 Cr
₹26 Cr	₹1 Cr	-₹20 Cr	-₹66 Cr	₹64 Cr
₹4 Cr	₹2 Cr	₹23 Cr	₹88 Cr	₹25 Cr
₹30 Cr	₹4 Cr	₹2 Cr	₹23 Cr	₹88 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Krsnaa Diagnostics Share Price

485.10-0.70 (-0.14%)

-38.60% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Open a free Demat account in minutes to start investing and screening .

Krsnaa Diagnostics Share Price

485.10-0.70 (-0.14%)

-38.60% past 1 Year

Shareholding summary

Promoters

27.11%

FII

3.84%

DII

4.33%

10.17%

Others

54.55%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
27.11%	27.11%	27.11%	27.11%	27.11%	27.11%
3.84%	4.28%	3.91%	4.17%	3.66%	3.40%
4.33%	4.34%	3.72%	3.70%	4.50%	4.61%
10.17%	10.17%	10.17%	10.15%	10.46%	9.63%
54.55%	54.10%	55.09%	54.87%	54.27%	55.25%

Bulk & block deals

Name

Hdfc Life Insurance Company Limited

Kitara Piin 1104

East Lane Capital Llp

Medimaze Solutions Private Limited

Miv Investment Services Private Limited

Invesco Mutual Fund

Somerset Indus Healthcare Fund I Limited

Acm Global Fund Vcc

Nk Securities Research Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
15 Jun 2026	Sell	15.13 Cr	₹539.25	2.81 L	Bulk	0.86497	BSE
15 Jun 2026	Purchase	15.13 Cr	₹539.25	2.81 L	Bulk	0.86497	BSE
12 Jun 2024	Sell	22.35 Cr	₹600.69	3.72 L	Bulk	1.146778	NSE
03 Oct 2023	Purchase	10.12 Cr	₹675	1.50 L	Block	0.462411	NSE
03 Oct 2023	Sell	10.12 Cr	₹675	1.50 L	Block	0.462411	NSE
28 Sep 2023	Purchase	10.79 Cr	₹675	1.60 L	Bulk	0.492957	NSE
28 Sep 2023	Sell	13.18 Cr	₹675.02	1.95 L	Bulk	0.602074	NSE
09 May 2023	Sell	44.12 Cr	₹495.27	8.91 L	Bulk	2.746278	NSE
09 May 2023	Purchase	34.21 Cr	₹495.25	6.91 L	Bulk	2.129731	NSE
16 Aug 2021	Purchase	20.94 Cr	₹1,031.31	2.03 L	Bulk	0.626018	NSE

Insider trading & SAST

Client name

Krsna Diagnostics (Mumbai) Pvt Ltd

Krsna Diagnostics (Mumbai) Private Limited

Icici Prudential Mutual Fund

Tata Small Cap Fund & Tata India Equity Fund Multipartner Sicav

Icici Prudential Mutual Fund

Krsna Diagnostics (Mumbai) Private Limited

Phi Capital Trust - Phi Capital Growth Fund - 1

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
15 Jan 2025	Promoter	Acquisition	0.07	2.37	0	—	22.93 K	27 Dec 2024	Market	7,65,685	SAST	29(2)	—
31 Dec 2024	Promoter Group	Acquisition	0.07101	2.37	2 Cr	₹870.89	22.93 K	27 Dec 2024	Market Purchase	7,65,685	Insider Trading	—	Equity Shares
06 Jun 2024	Promoter Group	Acquisition	0.139363	2.3	2.43 Cr	₹540.86	45 K	04 Jun 2024	Market Purchase	7,42,756	Insider Trading	—	Equity Shares
06 Feb 2024	Other	Disposal	2.08	3.01	0	—	6.28 L	14 Dec 2022 - 01 Feb 2024	Market	-9,71,138	SAST	29(2)	—
25 Oct 2023	Other	Acquisition	0.19	7.17	0	—	62.68 K	23 Oct 2023	Market	22,53,012	SAST	29(1)	—
27 Mar 2023	Other	Acquisition	0.03	5.02	0	—	12.13 K	22 Mar 2023	Market	15,78,573	SAST	29(1)	—
20 Dec 2022	Other	Acquisition	1.51	5.09	0	—	4.76 L	13 Dec 2022	Market	15,98,966	SAST	29(1)	—
14 Sep 2022	Promoter Group	Acquisition	0.414039	2.22	6.66 Cr	₹512.29	1.30 L	12 Sep 2022	Gift	6,97,756	Insider Trading	—	Equity Shares
21 Feb 2022	Connected Person	Acquisition	0.024524	15.88	46.45 L	₹603.25	7.70 K	18 Feb 2022	Market Purchase	49,84,967	Insider Trading	—	Equity Shares
21 Feb 2022	Connected Person	Acquisition	0.031849	15.85	60.49 L	₹604.94	10 K	17 Feb 2022	Market Purchase	49,77,267	Insider Trading	—	Equity Shares

Krsnaa Diagnostics Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Krsnaa Diagnostics Share Price

Krsnaa Diagnostics Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Krsnaa Diagnostics Share Price

Krsnaa Diagnostics Share Price

Oscillators

Moving averages

Krsnaa Diagnostics Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Krsnaa Diagnostics Share Price

Corporate Actions

Company details

Krsnaa Diagnostics Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Krsnaa Diagnostics Share Price

News

Krsnaa Diagnostics Reports Higher EBITDA Despite Year On Year Margin Compression

Krsnaa Diagnostics Reports Higher Revenue And Marginally Improved Quarterly Profit

Krsnaa Diagnostics Partners With AZmed To Improve Radiology Reporting Efficiency

Krsnaa Diagnostics Board Approves Diagnostic Equipment Sale Worth Up To Rs 120 Crores

Krsnaa Diagnostics posts lower Q1 profit on higher revenue

Krsnaa Diagnostics reports higher Q1 EBITDA with lower margin

Krsnaa Diagnostics posts marginally higher Q4 EBITDA with stable margins YoY

Krsnaa Diagnostics Q4 FY earnings show strong profit growth on steady revenue base

Krsnaa Diagnostics reports Profit after tax of 43.38 Crores, in the March 2026 quarter

Krsnaa Diagnostics appoints Chandra Prakash Singh as Interim CFO from April 17, 2026.

Krsnaa Diagnostics submits newspaper advertisement

Krsnaa Diagnostics submits notice of postal ballot

Krsnaa Diagnostics informs about analyst meet

Krsnaa Diagnostics raises Rs 430 crore via NCDs

Krsnaa Diagnostics Issues Rs 430 Crores Debentures to Asian Development Bank for 7-Year Term.

Krsnaa Diagnostics informs about analyst meet outcome

Krsnaa Diagnostics - Quaterly Results

Krsnaa Diagnostics Q3 EBITDA Up 3.1% YoY to Rs 46.50 Crores, Margin Slightly Down to 25.66%.

Krsnaa Diagnostics Q3FY26 Results: Revenue Growth Offsets Profit Decline

Krsnaa Diagnostics reports Profit after tax of 16.49 Crores, in the December 2025 quarter

Krsnaa Diagnostics Ltd Share Price Today

Krsnaa Diagnostics Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator